Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Polina Shindiapina

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Therapeutic Advances in Hematology|April 7, 2018
Pembrolizumab and its role in relapsed/refractory classical Hodgkin's lymphoma: evidence to date and clinical utilityPolina Shindiapina, Lapo Alinari
Molecular Biology of the Cell|March 5, 2010
Requirements for transitional endoplasmic reticulum site structure and function in Saccharomyces cerevisiaePolina Shindiapina, Charles Barlowe
British Journal of Haematology|July 22, 2014
A new hope: novel therapeutic approaches to treatment of chronic lymphocytic leukaemia with defects in TP53Polina Shindiapina, Jennifer R Brown, Alexey V Danilov
Expert Opinion on Therapeutic Targets|May 22, 2018
Recent advances in targeting protein arginine methyltransferase enzymes in cancer therapyEmily Smith, Wei Zhou, Polina Shindiapina, et al.
Frontiers in Oncology|October 26, 2020
Immunology of EBV-Related Lymphoproliferative Disease in HIV-Positive IndividualsPolina Shindiapina, Elshafa H Ahmed, Anna Mozhenkova, et al.
Journal of Personalized Medicine|June 24, 2022
Recent Advances in the Management of Relapsed and Refractory Peripheral T-Cell LymphomasZachary Braunstein, Miguel Ruiz, Walter Hanel, et al.
Journal of Clinical Medicine|May 28, 2022
Extranodal Natural Killer/T-Cell Lymphomas: Current Approaches and Future DirectionsJohn C Reneau, Polina Shindiapina, Zachary Braunstein, et al.
Transplantation and Cellular Therapy|June 24, 2026
Outcomes of Tocilizumab for Cytokine Release Syndrome After Post-Transplant CyclophosphamideTuan L Phan, Roberta Azbell, Hannah Choe, et al.
Vaccines|June 2, 2021
Targeted Delivery of BZLF1 to DEC205 Drives EBV-Protective Immunity in a Spontaneous Model of EBV-Driven Lymphoproliferative DiseaseElshafa Hassan Ahmed, Eric Brooks, Shelby Sloan, et al.
Cancers|March 11, 2023
A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's LymphomaWalter Hanel, Polina Shindiapina, David A Bond, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Therapeutic Advances in Hematology|April 7, 2018
Pembrolizumab and its role in relapsed/refractory classical Hodgkin's lymphoma: evidence to date and clinical utilityPolina Shindiapina, Lapo Alinari
Molecular Biology of the Cell|March 5, 2010
Requirements for transitional endoplasmic reticulum site structure and function in Saccharomyces cerevisiaePolina Shindiapina, Charles Barlowe
British Journal of Haematology|July 22, 2014
A new hope: novel therapeutic approaches to treatment of chronic lymphocytic leukaemia with defects in TP53Polina Shindiapina, Jennifer R Brown, Alexey V Danilov
Expert Opinion on Therapeutic Targets|May 22, 2018
Recent advances in targeting protein arginine methyltransferase enzymes in cancer therapyEmily Smith, Wei Zhou, Polina Shindiapina, et al.
Frontiers in Oncology|October 26, 2020
Immunology of EBV-Related Lymphoproliferative Disease in HIV-Positive IndividualsPolina Shindiapina, Elshafa H Ahmed, Anna Mozhenkova, et al.
Journal of Personalized Medicine|June 24, 2022
Recent Advances in the Management of Relapsed and Refractory Peripheral T-Cell LymphomasZachary Braunstein, Miguel Ruiz, Walter Hanel, et al.
Journal of Clinical Medicine|May 28, 2022
Extranodal Natural Killer/T-Cell Lymphomas: Current Approaches and Future DirectionsJohn C Reneau, Polina Shindiapina, Zachary Braunstein, et al.
Transplantation and Cellular Therapy|June 24, 2026
Outcomes of Tocilizumab for Cytokine Release Syndrome After Post-Transplant CyclophosphamideTuan L Phan, Roberta Azbell, Hannah Choe, et al.
Vaccines|June 2, 2021
Targeted Delivery of BZLF1 to DEC205 Drives EBV-Protective Immunity in a Spontaneous Model of EBV-Driven Lymphoproliferative DiseaseElshafa Hassan Ahmed, Eric Brooks, Shelby Sloan, et al.
Cancers|March 11, 2023
A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's LymphomaWalter Hanel, Polina Shindiapina, David A Bond, et al.
Pageof 2